What is the Trilogy Evo Ventilator?
The Philips Respironics Trilogy series portable ventilators are designed for home, hospital, and alternative care sites to provide invasive and noninvasive ventilator support for pediatric and adult patients. The Trilogy 100 is a portable ventilation system that runs off of Low flow O2, which can control volume and pressure in the ventilation, making it easier for the patient to breathe.
The Trilogy 200 Ventilator has all the features of the Trilogy 100, plus extra triggering sensitivity utilizing a proximal flow sensor, which decreases the work of breathing, providing increased comfort and patient/ventilator synchrony.
Philips Ventilator Recall
On June 14, 2021, Philips issued a recall notification for 18 different sleep apnea and ventilator machines due to potential health risks. On July 29, 2021, the U.S. Food and Drug Administration (FDA) identified the Philips Respironics recall as a Class 1 recall, the most serious type of recall.
What's the Problem?
Philips issued the ventilator recall because foam particles could enter the device’s air pathway, causing a range of potential health problems and toxic, carcinogenic effects for the user.
According to the FDA’s notice, the agency received more than 21,000 medical device reports (MDRs), including 124 reports of death, associated with the PE-PUR foam breakdown or suspected foam breakdown in Philips Respironics’ ventilator devices.
Within the MDRs received by FDA — both mandatory reports from Philips and voluntary reports from healthcare professionals, consumers, and patients — a range of injuries were reported, including cancer, pneumonia, asthma, other respiratory problems, infection, headache, cough, dyspnea (difficulty breathing), dizziness, nodules, and chest pain.
See all related medical device litigations our lawyers have covered.
Which Trilogy Evo Ventilators Were Recalled?
The recall affects Philips Trilogy Evo ventilators with Material Numbers DS2110X11B (USA) and KR2110X15B (Korea). Philips is also recalling certain repair kits with Part #1135257 and Lots between 210414 and 210524. They were distributed in the U.S. from April 15, 2021 through May 24, 2021.
The potential health risks of particulate exposure in defective Philips Trilogy Evo ventilator machines and other similar medical devices include:
- Chest pressure
- Respiratory issues
- Toxic effects
- Cancer (carcinogenic effects)
- Other health issues
Get a Free Trilogy Evo Ventilator Lawsuit Evaluation With Our Lawyers
The Medical Device Litigation Group at our law firm is an experienced team of lawyers that focus on the representation of plaintiffs in lawsuits.
Our Personal Injury Lawyers are handling individual litigation nationwide and currently accepting new Philips Trilogy Evo Ventilator cases in all 50 states.
If you or a loved one was diagnosed with cancer after using a recalled sleep apnea device or ventilator machine, you should contact our law firm immediately.
You may be entitled to financial compensation for medical expenses by filing a Trilogy Evo Ventilator Lawsuit and our lawyers can help you receive fair compensation.